Dear all,

On Thursday, February 9, 2023 from 12:00 p.m. to 1:00 p.m. ET (17:00-18:00 UTC)

Karen Akinsanya, President of Research & Development - Therapeutics, Schrödinger, Inc

     will present a zoom webinar titled

New Dimensions - How Computation Is Accelerating Structure Based Drug Design


This zoom webinar is free, but registration is required. Please see the registration link on the National Academies of Sciences, Engineering, and Medicine event page along with Karen Akinsanya's abstract and bio.

https://www.nationalacademies.org/event/02-09-2023/new-dimensions-how-computation-is-accelerating-structure-based-drug-design


A flyer for the webinar is also available
https://www.nationalacademies.org/documents/embed/link/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B/file/D35235E9052B1720EE8CE81C04DBE3730340ABCC0D93?noSaveAs=1


This is the second presentation in the series --
Advancing Drug Discovery: A Webinar Series of the National Academies of Sciences, Engineering, and Medicine
The series is being hosted jointly by the
  U.S. National Committee for Crystallography (USNC/Cr), the
U.S. National Committee for the International Union of Pure and Applied Chemistry (USNC/IUPAC) and the
  U.S. National Committee for CODATA.
More information about the series is on the NASEM website and it will be updated as additional webinars in the series are confirmed. The website also has links to recordings of "past events".

https://www.nationalacademies.org/our-work/advancing-drug-discovery-a-webinar-series-of-the-national-academies-of-sciences-engineering-and-medicine


Please forward this to any you think would be interested.

Sincerely,
Mitch


P.S. for those who missed the January 10, 2023 webinar presented by

  Ken Duncan, Deputy Director, The Bill & Melinda Gates Foundation
                         on
Pandemic Preparedness: Accelerating the Discovery of New Therapeutics

The recording is available on the National Academies of Sciences, Engineering, and Medicine event page along with Ken Duncan's abstract and bio.

https://www.nationalacademies.org/event/01-10-2023/pandemic-preparedness-accelerating-the-discovery-of-new-therapeutics


########################################################################

To unsubscribe from the CCP4BB list, click the following link:
https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1

This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list 
hosted by www.jiscmail.ac.uk, terms & conditions are available at 
https://www.jiscmail.ac.uk/policyandsecurity/
--- Begin Message ---


Dear all,

On Tuesday, January 10, 2023 from 12:00 p.m. to 1:00 p.m. ET (17:00-18:00 UTC)

  Ken Duncan, Deputy Director, The Bill & Melinda Gates Foundation

            will present a zoom webinar titled

Pandemic Preparedness: Accelerating the Discovery of New Therapeutics


This zoom webinar is free, but registration is required.
Please see the registration link on the National Academies of
Sciences, Engineering, and Medicine event page along with Ken Duncan's
abstract and bio.

https://www.nationalacademies.org/event/01-10-2023/pandemic-preparedness-accelerating-the-discovery-of-new-therapeutics

A flyer for the webinar is also available
https://www.nationalacademies.org/documents/embed/link/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B/file/D2B81A0E0DD6DA6A6113F7D9FA179F92E752290CFF6D?noSaveAs=1


This is the first presentation in a new series --
Advancing Drug Discovery: A Webinar Series of the National Academies
of Sciences, Engineering, and Medicine
The series is being hosted jointly by the
  U.S. National Committee for Crystallography (USNC/Cr), the
  U.S. National Committee for the International Union of Pure and
Applied Chemistry (USNC/IUPAC) and the
  U.S. National Committee for CODATA.
More information about the series is on the NASEM website and it will
be updated as additional webinars in the series are confirmed.

https://www.nationalacademies.org/our-work/advancing-drug-discovery-a-webinar-series-of-the-national-academies-of-sciences-engineering-and-medicine


Please forward this to any you think would be interested.

Sincerely,
Mitch


--- End Message ---

Reply via email to